Mycotoxin Occurrence and Risk Assessment in Gluten-Free Pasta through UHPLC-Q-Exactive Orbitrap MS
Abstract
:1. Introduction
2. Results and Discussion
2.1. Chromatographic and Mass Spectrometric Optimization
2.2. Method Validation
2.3. Mycotoxin Occurrence in Gluten-Free Pasta
2.4. Exposure Assessment
3. Conclusions
4. Materials and Methods
4.1. Chemicals and Reagents
4.2. Sampling
4.3. Sample Preparation
4.4. Ultra-High Performance Liquid Chromatography Couple to Q Exactive Orbitrap Mass Spectrometry (UHPLC-Q-Orbritrap HRMS) Analysis
4.5. Method Performance
4.6. Quality Assurance/Quality Control (QA/QC)
4.7. Mycotoxin Probable Daily Intakes Calculation
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Guandalini, S.; Assiri, A. Celiac disease: A review. JAMA Pediatrics 2014, 168, 272–278. [Google Scholar] [CrossRef] [PubMed]
- Roncoroni, L.; Elli, L.; Doneda, L.; Bascuñán, K.A.; Vecchi, M.; Morreale, F.; Scricciolo, A.; Lombardo, V.; Pellegrini, N. A retrospective study on dietary FODMAP intake in celiac patients following a gluten-free diet. Nutrients 2018, 10, 1769. [Google Scholar] [CrossRef] [Green Version]
- Foschia, M.; Horstmann, S.; Arendt, E.K.; Zannini, E. Nutritional therapy–Facing the gap between coeliac disease and gluten-free food. Int. J. Food Microbiol. 2016, 239, 113–124. [Google Scholar] [CrossRef]
- Markets and Markets. Gluten-Free Products Market by Type (Bakery Products, Snacks & RTE Products, Condiments & Dressings, Pizzas & Pastas), Distribution Channel (Conventional Stores, Specialty Stores and Drugstores & Pharmacies), Form & Region—Global Forecast to 2025. Available online: https://www.marketsandmarkets.com/Market-Reports/gluten-free-products-market-738.html (accessed on 15 March 2020).
- Saturni, L.; Ferretti, G.; Bacchetti, T. The gluten-free diet: Safety and nutritional quality. Nutrients 2010, 2, 16–34. [Google Scholar] [CrossRef] [Green Version]
- Brera, C.; Debegnach, F.; De Santis, B.; Di Ianni, S.; Gregori, E.; Neuhold, S.; Valitutti, F. Exposure assessment to mycotoxins in gluten-free diet for celiac patients. Food Chem. Toxicol. 2014, 69, 13–17. [Google Scholar] [CrossRef] [PubMed]
- Shephard, G.S. Risk assessment of aflatoxins in food in Africa. Food Addit. Contam. Part A 2008, 25, 1246–1256. [Google Scholar] [CrossRef]
- Reddy, K.R.N.; Abbas, H.K.; Abel, C.A.; Shier, W.T.; Oliveira, C.A.F.; Raghavender, C.R. Mycotoxin contamination of commercially important agricultural commodities. Toxin Rev. 2009, 28, 154–168. [Google Scholar] [CrossRef]
- Nikiema, P.N.; Worrillow, L.; Traore, A.S.; Wild, C.P.; Turner, P.C. Fumonisin contamination of maize in Burkina Faso, West Africa. Food Addit. Contam. 2004, 21, 865–870. [Google Scholar] [CrossRef]
- Domijan, A.; Peraica, M.; Cvjetković, B.; Turčin, S.; Jurjević, Ž.; Ivić, D. Mould contamination and co-occurrence of mycotoxins in maize grain in Croatia. Acta Pharm. 2005, 55, 349–356. [Google Scholar]
- Rodríguez-Carrasco, Y.; Moltó, J.C.; Berrada, H.; Mañes, J. A survey of trichothecenes, zearalenone and patulin in milled grain-based products using GC–MS/MS. Food Chem. 2014, 146, 212–219. [Google Scholar] [CrossRef] [PubMed]
- Munkvold, G.P.; Arias, S.; Taschl, I.; Gruber-Dorninger, C. Mycotoxins in corn: Occurrence, impacts, and management. In Corn; AACC International Press: Washington, DC, USA, 2019; pp. 235–287. [Google Scholar] [CrossRef]
- Rodríguez-Carrasco, Y.; Izzo, L.; Gaspari, A.; Graziani, G.; Mañes, J.; Ritieni, A. Simultaneous Determination of AFB1 and AFM1 in Milk Samples by Ultra High Performance Liquid Chromatography Coupled to Quadrupole Orbitrap Mass Spectrometry. Beverages 2018, 4, 43. [Google Scholar] [CrossRef] [Green Version]
- European Commission 2006. Commission Regulation (EC) No. 1881/2006 setting maximum levels for certain contaminants in foodstuffs. Off. J. Eur. Union 2006, L364, 5–24. [Google Scholar]
- European Commission 2007. Commission Regulation (EC) No 1126/2007 of 28 September 2007 amending Regulation (EC) No 1881/2006 setting maximum levels for certain contaminants in foodstuffs as regards Fusarium toxins in maize and maize products. Off. J. Eur. Union 2007, L255, 14–17. [Google Scholar]
- Mohamed, M.K.; Takyi-Williams, J.; Baudot, B.; Grobler, A. Development and validation of a LC-HRMS method for the quantification of cannabinoids and their metabolites in human plasma. Eur. J. Pharm. Sci. 2021, 159, 105705. [Google Scholar] [CrossRef] [PubMed]
- Tolosa, J.; Graziani, G.; Gaspari, A.; Chianese, D.; Ferrer, E.; Mañes, J.; Ritieni, A. Multi-Mycotoxin Analysis in Durum Wheat Pasta by Liquid Chromatography Coupled to Quadrupole Orbitrap Mass Spectrometry. Toxins 2017, 9, 59. [Google Scholar] [CrossRef] [Green Version]
- Esposito, F.; Fasano, E.; Scognamiglio, G.; Nardone, A.; Triassi, M.; Cirillo, T. Exposure assessment to fumonisins B1, B2 and B3 through consumption of gluten-free foodstuffs intended for people affected by celiac disease. Food Chem. Toxicol. 2016, 97, 395–401. [Google Scholar] [CrossRef] [PubMed]
- Magro, S.L.; Campaniello, M.; Nardiello, D.; Muscarella, M. Assessment of Fumonisins B1 and B2 levels in commercial maize-based food products by Liquid Chromatography with Fluorimetric detection and post column chemical derivatization. J. Food Sci. 2011, 76, T1–T4. [Google Scholar] [CrossRef]
- Dall’Asta, C.; Galaverna, G.; Mangia, M.; Sforza, S.; Dossena, A.; Marchelli, R. Free and bound fumonisins in gluten-free food products. Mol. Nutr. Food Res. 2009, 53, 492–499. [Google Scholar] [CrossRef]
- Dall’Asta, C.; Scarlato, A.P.; Galaverna, G.; Brighenti, F.; Pellegrini, N. Dietary exposure to fumonisins and evaluation of nutrient intake in a group of adult celiac patients on a gluten-free diet. Mol. Nutr. Food Res. 2012, 56, 632–640. [Google Scholar] [CrossRef]
- Cano-Sancho, G.; Ramos, A.J.; Marín, S.; Sanchis, V. Presence and co-occurrence of aflatoxins, deoxynivalenol, fumonisins and zearalenone in gluten-free and ethnic foods. Food Control 2012, 26, 282–286. [Google Scholar] [CrossRef]
- Bryła, M.; Roszko, M.; Szymczyk, K.; Jędrzejczak, R.; Słowik, E.; Obiedziński, M.W. Effect of baking on reduction of free and hidden fumonisins in gluten-free bread. J. Agric. Food Chem. 2014, 62, 10341–10347. [Google Scholar] [CrossRef]
- Huong, B.T.M.; Do, T.T.; Madsen, H.; Brimer, L.; Dalsgaard, A. Aflatoxins and fumonisins in rice and maize staple cereals in Northern Vietnam and dietary exposure in different ethnic groups. Food Control 2016, 70, 191–200. [Google Scholar] [CrossRef]
- Herrera, M.; Bervis, N.; Carramiñana, J.J.; Juan, T.; Herrera, A.; Ariño, A.; Lorán, S. Occurrence and exposure assessment of aflatoxins and deoxynivalenol in cereal-based baby foods for infants. Toxins 2019, 11, 150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Decleer, M.; Rajkovic, A.; Sas, B.; Madder, A.; De Saeger, S. Development and validation of ultra-high-performance liquid chromatography–tandem mass spectrometry methods for the simultaneous determination of beauvericin, enniatins (A, A1, B, B1) and cereulide in maize, wheat, pasta and rice. J. Chromatogr. A 2016, 1472, 35–43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leclercq, C.; Arcella, D.; Piccinelli, S.; Le Donne, C.; Turrini, A. The Italian National Food Consumption Survey INRAN-SCAI 2005–2006: Main results in terms of food consumption. Public Health Nutr. 2009, 12, 2504–2532. [Google Scholar] [CrossRef] [Green Version]
- King, J.A.; Jeong, J.; Underwood, F.E.; Quan, J.; Panaccione, N.; Windsor, J.W.; Coward, S.; De Bruyn, J.; Ronksley, P.E.; de Shaheen, A.A.; et al. Incidence of celiac disease is increasing over time: A systematic review and meta-analysis. Am. J. Gastroenterol. 2020, 115, 507–525. [Google Scholar] [CrossRef] [PubMed]
- European Commission 2006. Commission Regulation (EC) No. 2006/401/EC of 23 February 2006 laying down the methods of sampling and analysis for the official control of the levels of mycotoxins in foodstuffs. Off. J. Eur. Union 2006, L70, 12–34. [Google Scholar]
- Rodríguez-Carrasco, Y.; Castaldo, L.; Gaspari, A.; Graziani, G.; Ritieni, A. Development of an UHPLC-Q-Orbitrap HRMS method for simultaneous determination of mycotoxins and isoflavones in soy-based burgers. LWT 2019, 99, 34–42. [Google Scholar] [CrossRef]
- European Commission 2002. Commission decision 2002/657/EC of 12 August 2002 implementing Council directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Union 2002, L221, 8–36. [Google Scholar]
- Rodríguez-Carrasco, Y.; Ruiz, M.J.; Font, G.; Berrada, H. Exposure estimates to Fusarium mycotoxins through cereals intake. Chemosphere 2013, 93, 2297–2303. [Google Scholar] [CrossRef]
Mycotoxin | Retention Time (min) | Elemental Composition | Adduct Ion | Theoretical Mass (m/z) | Measured Mass (m/z) | Accuracy (Δ ppm) |
---|---|---|---|---|---|---|
3-AcDON | 3.83 | C17H22O7 | [M + H]+ | 339.14383 | 339.14331 | −1.53 |
15-AcDON | 4.02 | C17H22O7 | [M + H]+ | 339.14383 | 339.14331 | −1.53 |
DON | 4.18 | C15H20O6 | [M + HCOOH]− | 341.12451 | 341.12454 | 0.09 |
NIV | 4.35 | C15H20O7 | [M + H]+ | 313.12810 | 313.12785 | −0.74 |
FUS-X | 4.47 | C17H22O8 | [M + H]+ | 355.13874 | 355.13866 | −0.92 |
NEO | 4.58 | C19H26O8 | [M + NH4]+ | 400.19659 | 400.19653 | −0.15 |
AFG2 | 4.61 | C17H14O7 | [M + H]+ | 331.08123 | 331.08032 | −2.75 |
AFG1 | 4.79 | C17H12O7 | [M + H]+ | 329.06553 | 329.06553 | −0.05 |
AFB2 | 4.98 | C17H14O6 | [M + H]+ | 315.08631 | 315.08521 | −3.49 |
AFB1 | 5.02 | C17H12O6 | [M + H]+ | 313.07066 | 313.06958 | −3.45 |
HT-2 | 5.63 | C22H32O8 | [M + NH4]+ | 442.24354 | 442.24323 | −0.70 |
FB1 | 6.03 | C34H59NO15 | [M + H]+ | 722.39575 | 722.39539 | −0.50 |
T-2 | 6.13 | C24H34O9 | [M + NH4]+ | 484.25411 | 484.25418 | 0.14 |
OTA | 6.50 | C20H18NO6Cl | [M + H]+ | 404.08954 | 404.08801 | −3.79 |
ZON | 6.53 | C18H22O5 | [M + H]+ | 317.13945 | 317.13910 | −1.10 |
FB2 | 6.78 | C34H59NO14 | [M + H]+ | 706.40083 | 706.40192 | 1.54 |
ENN B | 7.81 | C33H57N3O9 | [M + NH4]+ | 657.44331 | 657.44299 | −0.49 |
BEA | 7.96 | C45H57N3O9 | [M + NH4]+ | 801.44330 | 801.44323 | −0.09 |
ENN B1 | 8.06 | C34H59N3O9 | [M + NH4]+ | 671.45986 | 671.45923 | −0.94 |
ENN A1 | 8.11 | C35H61N3O9 | [M + NH4]+ | 685.47461 | 685.47351 | −1.60 |
ENN A | 8.24 | C36H63N3O9 | [M + NH4]+ | 699.49026 | 699.48926 | −1.43 |
Mycotoxin | Recovery (%) | Repeatability RSD % | Reproducibility RSD % | SSE (%) | LOD (µg/kg) | LOQ (µg/kg) | Calibration Curves | r2 | ||
---|---|---|---|---|---|---|---|---|---|---|
12.5 µg/kg | 62.5 µg/kg | 125 (500 *) µg/kg | ||||||||
3-AcDON | 71 | 92 | 83 | 10.2 | 10.5 | 73 | 1.1 | 3.3 | y = 282,673x | 0.992 |
15-AcDON | 70 | 94 | 82 | 9.9 | 10.1 | 75 | 1.1 | 3.3 | y = −382,359 + 25,694.5x | 0.992 |
DON | 89 | 85 | 98 (95 *) | 5.8 | 6.7 | 94 | 2.1 | 6.4 | y = −451,745 + 27,781.9x | 0.997 |
NIV | 68 | 79 | 75 | 6.2 | 5.6 | 75 | 5.4 | 16.1 | y = −558,243 + 37,636.8x | 0.996 |
FUS-X | 97 | 110 | 90 | 10.5 | 10.1 | 48 | 7.8 | 23.5 | y = −593,326 + 10,261x | 0.997 |
NEO | 114 | 118 | 122 | 5.2 | 4.0 | 39 | 2.3 | 6.9 | y = −1.20903 × 106 + 275,818x | 0.997 |
AFG2 | 102 | 112 | 98 | 6.5 | 7.2 | 78 | 0.10 | 0.23 | y = 71,914 + 3.10136 × 106x | 0.996 |
AFG1 | 95 | 110 | 102 | 6.3 | 7.5 | 84 | 0.10 | 0.23 | y = 68,876 + 3.09432 × 106x | 0.997 |
AFB2 | 105 | 125 | 120 | 8.4 | 10.4 | 80 | 0.06 | 0.17 | y = 71,914.2 + 3.13427 × 106x | 0.992 |
AFB1 | 121 | 120 | 124 | 1.8 | 2.1 | 83 | 0.06 | 0.17 | y = 72,965.1 + 3.08148 × 106x | 0.994 |
HT-2 toxin | 112 | 95 | 98 | 8.7 | 9.1 | 87 | 1.2 | 3.6 | y = −146,011 + 186,971x | 0.997 |
FB1 | 104 | 115 | 99 (104 *) | 8.3 | 8.2 | 72 | 1.9 | 5.6 | y = −285,447 + 74,040.9x | 0.998 |
T-2 toxin | 121 | 107 | 98 | 9.4 | 11.6 | 66 | 0.8 | 2.5 | y = −1.7152 × 106 + 1.58156 × 106x | 0.999 |
OTA | 95 | 100 | 118 | 10.3 | 12.1 | 91 | 0.08 | 0.25 | y = −40,0195 + 21,4596x | 0.998 |
ZON | 90 | 93 | 105 | 8.7 | 7.9 | 87 | 0.13 | 0.38 | y = 1.37666 × 106 + 937,950x | 0.997 |
FB2 | 99 | 110 | 115 (108 *) | 7.1 | 8.2 | 85 | 0.26 | 0.76 | y = −414,600 + 89,251.2x | 0.998 |
ENN B | 90 | 108 | 117 | 7.4 | 10.7 | 41 | 0.05 | 0.16 | y = −497,411 + 82,621.5x | 0.990 |
BEA | 99 | 96 | 112 | 6.2 | 8.5 | 88 | 3.6 | 10.9 | y = −272,121 + 58,199.7x | 0.995 |
ENN B1 | 102 | 123 | 120 | 7.8 | 11.4 | 38 | 0.05 | 0.76 | y = −435,829 + 78,581x | 0.992 |
ENN A1 | 113 | 110 | 109 | 3.5 | 2.1 | 86 | 0.10 | 0.30 | y = −476,813 + 79,612.5x | 0.996 |
ENN A | 123 | 118 | 115 | 3.7 | 4.0 | 99 | 0.05 | 0.14 | y = −387,123 + 68,591.5x | 0.998 |
Mycotoxin | Incidence (%) | Range (Mean) (µg/kg) | IARC Classification | MLs (EC) No. 1881/2006 (µg/kg) |
---|---|---|---|---|
NIV | 33.3 | 209.2–367.6 (241.3) | 3 | No limits established |
DON | 66.7 | 182.2–377.4 (239.8) | 3 | 750 |
HT-2 toxin | 9.5 | 18.2–26.3 (22.2) | NC | No limits established |
ZON | 71.4 | 9.2–26.9 (13.5) | 3 | 20–200 *** |
FB1 | 90.5 | 39.9–246.9 (116.2) | 2B | 200 **–400 |
FB2 | 33.3 | 44.0–53.4 (48.0) | 2B | |
ENN A1 | 4.8 | 1.7 * | NC | No limits established |
BEA | 9.5 | 17.3–21.9 (19.6) | NC | No limits established |
Mycotoxin | Age/Sex (Years) | Bodyweight (kg) * | Mean Consumption (g) * | Consumption P95 (g) * | Contamination Range (µg/kg) | Exposure (ng/kg bw/day) | Exposure P95 (ng/kg bw/day) | TDI (ng/kg bw/day) |
---|---|---|---|---|---|---|---|---|
NIV | 3–9.9 M/F | 26.1 | 58.2 | 104.9 | 209.2–367.6 | 466.5–819.7 | 840.8–1477.4 | 1200 (SCF, 2013) |
10–17.9 M | 57.1 | 63.6 | 128 | 233.0–409.4 | 468.9–824.0 | |||
10–17.9 F | 49.1 | 56.6 | 105.3 | 241.1–423.7 | 448.6–788.3 | |||
18–64.9 M | 78.4 | 60.3 | 118.4 | 160.9–282.7 | 315.9–555.1 | |||
18–64.9 F | 62.2 | 47.4 | 100 | 159.4–280.1 | 336.3–590.9 | |||
≥65 M | 78.1 | 61.1 | 109.6 | 163.6–287.6 | 293.6–515.9 | |||
≥65 F | 65 | 50.7 | 100.6 | 163.2–286.7 | 323.8–569.0 | |||
DON | 3–9.9 M/F | 26.1 | 58.2 | 104.9 | 182.2–377.4 | 406.3–841.5 | 732.3–1516.8 | 1000 (SCF, 2004) |
10–17.9 M | 57.1 | 63.6 | 128 | 202.9–420.4 | 408.4–846.0 | |||
10–17.9 F | 49.1 | 56.6 | 105.3 | 210.0–435.0 | 390.7–809.4 | |||
18–64.9 M | 78.4 | 60.3 | 118.4 | 140.1–290.3 | 275.1–570.0 | |||
18–64.9 F | 62.2 | 47.4 | 100 | 138.8–287.6 | 292.9–606.7 | |||
≥65 M | 78.1 | 61.1 | 109.6 | 142.5–295.2 | 255.7–529.6 | |||
≥65 F | 65 | 50.7 | 100.6 | 142.1–294.4 | 282.0–584.1 | |||
HT-2 toxin | 3–9.9 M/F | 26.1 | 58.2 | 104.9 | 18.2–26.3 | 40.6–58.6 | 73.1–105.7 | Σ T-2 + HT-2 100 (SCF, 2011a) |
10–17.9 M | 57.1 | 63.6 | 128 | 20.3–29.3 | 40.8–59.0 | |||
10–17.9 F | 49.1 | 56.6 | 105.3 | 21.0–30.3 | 39.0–56.4 | |||
18–64.9 M | 78.4 | 60.3 | 118.4 | 14.0–20.2 | 27.5–39.7 | |||
18–64.9 F | 62.2 | 47.4 | 100 | 13.9-20.0 | 29.3–42.3 | |||
≥65 M | 78.1 | 61.1 | 109.6 | 14.2–20.6 | 25.5–37.0 | |||
≥65 F | 65 | 50.7 | 100.6 | 14.2–20.5 | 28.2–40.7 | |||
ZON | 3–9.9 M/F | 26.1 | 58.2 | 104.9 | 9.2–26.9 | 20.5–60.0 | 37.0–108.1 | 250 (SCF, 2011b) |
10–17.9 M | 57.1 | 63.6 | 128 | 10.2–30.0 | 20.6–60.3 | |||
10–17.9 F | 49.1 | 56.6 | 105.3 | 10.6–31.0 | 19.7–57.7 | |||
18–64.9 M | 78.4 | 60.3 | 118.4 | 7.1–20.7 | 13.9–40.6 | |||
18–64.9 F | 62.2 | 47.4 | 100 | 7.0–20.5 | 14.8–43.2 | |||
≥65 M | 78.1 | 61.1 | 109.6 | 7.2–21.0 | 12.9–37.7 | |||
≥65 F | 65 | 50.7 | 100.6 | 7.2–21.0 | 14.2–41.6 | |||
FB1 | 3–9.9 M/F | 26.1 | 58.2 | 104.9 | 39.9–246.9 | 89.0–550.6 | 160.4–992.3 | Σ FB1 + FB2 2000 (SCF, 2003) |
10–17.9 M | 57.1 | 63.6 | 128 | 44.4–275.0 | 89.4–553.5 | |||
10–17.9 F | 49.1 | 56.6 | 105.3 | 46.0–284.6 | 85.6–529.5 | |||
18–64.9 M | 78.4 | 60.3 | 118.4 | 30.7–189.9 | 60.3–372.9 | |||
18–64.9 F | 62.2 | 47.4 | 100 | 30.4–188.2 | 64.1–397.0 | |||
≥65 M | 78.1 | 61.1 | 109.6 | 31.2–193.2 | 56.0–346.5 | |||
≥65 F | 65 | 50.7 | 100.6 | 31.1–192.6 | 61.8–382.1 | |||
FB2 | 3–9.9 M/F | 26.1 | 58.2 | 104.9 | 44.0–53.4 | 98.1–119.1 | 176.8–214.6 | Σ FB1 + FB2 2000 |
10–17.9 M | 57.1 | 63.6 | 128 | 49.0–59.5 | 98.6–119.7 | |||
10–17.9 F | 49.1 | 56.6 | 105.3 | 50.7–61.6 | 94.4–-114.5 | |||
18–64.9 M | 78.4 | 60.3 | 118.4 | 33.8–41.1 | 66.4–80.6 | |||
18–64.9 F | 62.2 | 47.4 | 100 | 33.5–40.7 | 70.7–85.9 | |||
≥65 M | 78.1 | 61.1 | 109.6 | 34.4–41.8 | 61.7–74.9 | |||
≥65 F | 65 | 50.7 | 100.6 | 34.3–41.7 | 68.1–82.6 | |||
ENN A1 | 3–9.9 M/F | 26.1 | 58.2 | 104.9 | 1.7 | 3.8 | 6.8 | No TDI established |
10–17.9 M | 57.1 | 63.6 | 128 | 1.9 | 3.8 | |||
10–17.9 F | 49.1 | 56.6 | 105.3 | 1.9 | 3.6 | |||
18–64.9 M | 78.4 | 60.3 | 118.4 | 1.3 | 2.6 | |||
18–64.9 F | 62.2 | 47.4 | 100 | 1.3 | 2.7 | |||
≥65 M | 78.1 | 61.1 | 109.6 | 1.3 | 2.4 | |||
≥65 F | 65 | 50.7 | 100.6 | 1.3 | 2.6 | |||
BEA | 3–9.9 M/F | 26.1 | 58.2 | 104.9 | 17.3–21.9 | 38.6–48.8 | 69.5–88.0 | No TDI established |
10–17.9 M | 57.1 | 63.6 | 128 | 19.3–24.4 | 38.8–49.1 | |||
10–17.9 F | 49.1 | 56.6 | 105.3 | 19.9–25.2 | 37.1–47.0 | |||
18–64.9 M | 78.4 | 60.3 | 118.4 | 13.3–16.8 | 26.1–33.1 | |||
18–64.9 F | 62.2 | 47.4 | 100 | 13.2–16.7 | 27.8–35.2 | |||
≥65 M | 78.1 | 61.1 | 109.6 | 13.5–17.1 | 24.3–30.7 | |||
≥65 F | 65 | 50.7 | 100.6 | 13.5–17.1 | 26.8–33.9 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tolosa, J.; Rodríguez-Carrasco, Y.; Graziani, G.; Gaspari, A.; Ferrer, E.; Mañes, J.; Ritieni, A. Mycotoxin Occurrence and Risk Assessment in Gluten-Free Pasta through UHPLC-Q-Exactive Orbitrap MS. Toxins 2021, 13, 305. https://doi.org/10.3390/toxins13050305
Tolosa J, Rodríguez-Carrasco Y, Graziani G, Gaspari A, Ferrer E, Mañes J, Ritieni A. Mycotoxin Occurrence and Risk Assessment in Gluten-Free Pasta through UHPLC-Q-Exactive Orbitrap MS. Toxins. 2021; 13(5):305. https://doi.org/10.3390/toxins13050305
Chicago/Turabian StyleTolosa, Josefa, Yelko Rodríguez-Carrasco, Giulia Graziani, Anna Gaspari, Emilia Ferrer, Jordi Mañes, and Alberto Ritieni. 2021. "Mycotoxin Occurrence and Risk Assessment in Gluten-Free Pasta through UHPLC-Q-Exactive Orbitrap MS" Toxins 13, no. 5: 305. https://doi.org/10.3390/toxins13050305